Table 1 Demographic and clinical characteristics of the three treatment groups
Charactersitic | Category | OP+/−a(C)RT N (%) | CRT N (%) | RT N (%) |
|---|---|---|---|---|
Total | 684 (100) | 40 (100) | 45 (100) | |
Age (continuous)a | 61.9 (9.7) | 61.2 (11.1) | 64.6 (9.8) | |
Sex | Males | 626 (91.5) | 33 (82.5) | 36 (80.0) |
Females | 58 (8.5) | 7 (17.5) | 9 (20.0) | |
CCI | 0 | 494 (72.2) | 33 (82.5) | 22 (48.9) |
1 | 100 (14.6) | 1 (2.5) | 15 (33.3) | |
2 | 63 (9.2) | 5 (12.5) | 6 (13.3) | |
3+ | 27 (3.9) | 1 (2.5) | 2 (4.4) | |
Tumour location | glottic | 435 (63.6) | 8 (20.0) | 23 (51.1) |
supraglottic | 168 (24.6) | 22 (55.0) | 14 (31.1) | |
subglottic | 13 (1.9) | 1 (2.5) | 1 (2.2) | |
transglottic | 42 (6.1) | 6 (15.0) | 3 (6.7) | |
unknown | 26 (3.8) | 3 (7.5) | 4 (8.9) | |
Stage | I | 304 (44.4) | 3 (7.5) | 10 (22.2) |
II | 142 (20.8) | 7 (17.5) | 15 (33.3) | |
III | 103 (15.1) | 10 (25.0) | 6 (13.3) | |
IV | 135 (19.7) | 20 (50.0) | 14 (31.1) | |
T stage | 1 | 319 (46.6) | 5 (12.5) | 12 (26.7) |
2 | 176 (25.7) | 11 (27.5) | 18 (40.0) | |
3 | 103 (15.1) | 11 (27.5) | 7 (15.6) | |
4 | 86 (12.6) | 13 (32.5) | 8 (17.8) | |
N stage | 0 | 528 (77.2) | 20 (50.0) | 30 (66.7) |
1 | 40 (5.8) | 3 (7.5) | 4 (8.9) | |
2 | 75 (11.0) | 12 (30.0) | 8 (17.8) | |
3 | 3 (0.4) | 3 (7.5) | 2 (4.4) | |
unknown | 38 (5.6) | 2 (5.0) | 1 (2.2) | |
Grading | 1 | 47 (6.9) | 1 (2.5) | 3 (6.7) |
2 | 420 (61.4) | 16 (40.0) | 16 (35.6) | |
3,4 | 118 (17.3) | 5 (12.5) | 7 (15.6) | |
0, x | 99 (14.5) | 18 (45.0) | 19 (42.2) | |
Laser | 452 (66.1) | − | − | |
Partial resection | 59 (8.6) | − | − | |
TL | 173 (25.3) | − | − | |
RT | Primary | − | − | 45 (100) |
Adjuvant | 145 (21.2) | − | − | |
RCT | Primary | − | 40 (100) | − |
Adjuvant | 22 (3.2) | − |